Article info
PDFSpecial populations
Original research
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19
- Correspondence to Prof Giulio G. Stefanini, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele 20090, Italy; giulio.stefanini{at}gmail.com
Citation
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19
Publication history
- Received May 10, 2020
- Revised July 16, 2020
- Accepted July 28, 2020
- First published August 14, 2020.
Online issue publication
January 18, 2021
Article Versions
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage